As his first official act of Nobel Week, 2018 Nobel Laureate in
Physiology or Medicine Jim Allison, Ph.D., on Thursday signed the
bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s
Old Town. The chair-signing is part of a traditional museum visit by
Nobel winners, and launches the week’s events.
Allison, chair of Immunology at MD Anderson, along with co-winner Tasuku Honjo, M.D., Ph.D., of Kyoto University...
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone...
Researchers in MD Anderson’s Leukemia department played central roles in the studies of two drugs, glasdegib and venetoclax, approved in November...
Despite a plethora of new and promising treatments available, lung
cancer remains the leading cause of cancer death in the United States,
and will claim more than 150,000 lives this year. November is Lung
Cancer Awareness Month, a time to bring the disease into focus and
educate people about prevention, screening and treatments that save
lives.
MD Anderson’s Lung Cancer Moon Shot™ team is committed to making new, patient-guided...
Pancreatic cancer is one of the most lethal types of cancer, expected to cause more than 44,000 deaths in the U.S. this year. It’s a deadly...
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance...
Minimally invasive hysterectomies, which are known for shorter, less stressful recovery periods, are considered easier on patients. But two...
Triple-negative breast cancer (TNBC) makes up 15 to 20 percent of breast cancer diagnoses. The condition often is considered a single disease...
Over the past decade, immune checkpoint inhibitors have shown success in treating several types of cancer, including melanoma, non-small cell...
MD Anderson researchers have discovered that a protein called angiogenin (ANG) serves as a potential biomarker useful for stratifying pancreatic...